These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11020121)

  • 1. Mexiletine in the treatment of torticollis and generalized dystonia.
    Lucetti C; Nuti A; Gambaccini G; Bernardini S; Brotini S; Manca ML; Bonuccelli U
    Clin Neuropharmacol; 2000; 23(4):186-9. PubMed ID: 11020121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mexiletine in the treatment of spasmodic torticollis.
    Ohara S; Hayashi R; Momoi H; Miki J; Yanagisawa N
    Mov Disord; 1998 Nov; 13(6):934-40. PubMed ID: 9827618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of patients with tardive dystonia with olanzapine.
    Lucetti C; Bellini G; Nuti A; Bernardini S; Dell'Agnello G; Piccinni A; Maggi L; Manca L; Bonuccelli U
    Clin Neuropharmacol; 2002; 25(2):71-4. PubMed ID: 11981231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of abobotulinumtoxinA liquid formulation in cervical dystonia: A randomized-controlled trial.
    Poewe W; Burbaud P; Castelnovo G; Jost WH; Ceballos-Baumann AO; Banach M; Potulska-Chromik A; Ferreira JJ; Bihari K; Ehler E; Bares M; Dzyak LA; Belova AN; Pham E; Liu WJ; Picaut P
    Mov Disord; 2016 Nov; 31(11):1649-1657. PubMed ID: 27653448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent onabotulinumtoxinA treatment of cervical dystonia and concomitant migraine.
    Winner PK; Sadowsky CH; Martinez WC; Zuniga JA; Poulette A
    Headache; 2012 Sep; 52(8):1219-25. PubMed ID: 22607530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of selective ramisectomy for botulinum toxin resistant torticollis.
    Ford B; Louis ED; Greene P; Fahn S
    J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):472-8. PubMed ID: 9771768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep brain stimulation for generalised dystonia and spasmodic torticollis.
    Bittar RG; Yianni J; Wang S; Liu X; Nandi D; Joint C; Scott R; Bain PG; Gregory R; Stein J; Aziz TZ
    J Clin Neurosci; 2005 Jan; 12(1):12-6. PubMed ID: 15639404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).
    Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD
    Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective blinded evaluation of deep brain stimulation for the treatment of secondary dystonia and primary torticollis syndromes.
    Pretto TE; Dalvi A; Kang UJ; Penn RD
    J Neurosurg; 2008 Sep; 109(3):405-9. PubMed ID: 18759568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of spasmodic torticollis with mexiletine: a case report.
    Ohara S; Miki J; Momoi H; Unno H; Shindo M; Yanagisawa N
    Mov Disord; 1997 May; 12(3):466-9. PubMed ID: 9159753
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of botulinum toxin injections for spasmodic torticollis of tardive dystonia.
    Kaufman DM
    J Neuropsychiatry Clin Neurosci; 1994; 6(1):50-3. PubMed ID: 8148637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilateral deep brain stimulation for cervical dystonia in patients with previous peripheral surgery.
    Capelle HH; Blahak C; Schrader C; Baezner H; Hariz MI; Bergenheim T; Krauss JK
    Mov Disord; 2012 Feb; 27(2):301-4. PubMed ID: 22173964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inter-rater reliability while using the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) in patients with cervical dystonia].
    Kaji R; Osawa M; Yanagisawa N
    Brain Nerve; 2009 Jan; 61(1):65-71. PubMed ID: 19177808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized double-blind crossover trial comparing subthalamic and pallidal deep brain stimulation for dystonia.
    Schjerling L; Hjermind LE; Jespersen B; Madsen FF; Brennum J; Jensen SR; Løkkegaard A; Karlsborg M
    J Neurosurg; 2013 Dec; 119(6):1537-45. PubMed ID: 24116723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the burden of illness from cervical dystonia using the Toronto Western Spasmodic Torticollis Rating Scale scores and health utility: a meta-analysis of baseline patient-level clinical trial data.
    Jen MH; Kurth H; Iheanacho I; Dinet J; Gabriel S; Wasiak R; Jost WH
    J Med Econ; 2014 Nov; 17(11):803-9. PubMed ID: 25155368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimal clinically important change in the Toronto Western Spasmodic Torticollis Rating Scale.
    Espay AJ; Trosch R; Suarez G; Johnson J; Marchese D; Comella C
    Parkinsonism Relat Disord; 2018 Jul; 52():94-97. PubMed ID: 29530726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of clinical rating scales in treatment of cervical dystonia with botulinum toxin.
    Tarsy D
    Mov Disord; 1997 Jan; 12(1):100-2. PubMed ID: 8990061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin B: a review of its therapeutic potential in the management of cervical dystonia.
    Figgitt DP; Noble S
    Drugs; 2002; 62(4):705-22. PubMed ID: 11893235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Torticaput versus Torticollis: Clinical Effects with Modified Classification and Muscle Selection.
    Jost WH
    Tremor Other Hyperkinet Mov (N Y); 2019; 9():. PubMed ID: 31413892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dystonia discomfort scale (DDS): a novel instrument to monitor the temporal profile of botulinum toxin therapy in cervical dystonia.
    Dressler D; Kupsch A; Seitzinger A; Paus S
    Eur J Neurol; 2014 Mar; 21(3):459-62. PubMed ID: 24433495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.